Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The full schedule uses 5660 injections, and each 70 mg GLOW vial contains 25 standard doses by mass
Phase III results for retatrutide are set to be released later in 2025 and in early 2026, but an earlier phase II trial recorded between a 7.2% and 17.5% reduction in body weight after 24 weeks, depending on the dose (7.2% on 1mg, 17.5% on 12mg), and up to a 24.2% reduction in body weight after 48 weeks for those on 12mg (-8.7% change for those on 1mg) 8
Revita targets the duodenum, a root contributor to metabolic disease, through a single endoscopic procedure that fits within routine GI practice, said Dr
Zheng Y, Yang D, Gao B, Huang S, Tang Y, Wa Q, Dong Y, Yu S, Huang J, Huang S
Share your goals with family and friends who can provide encouragement and accountability
Each 1 percentage point reduction in body weight from baseline lowered the likelihood for GLP-1 discontinuation by 3%
US$ 21.39
US$ 23.26
US$ 27.15
US$ 23.03
US$ 22.11
